ArticleBMC neurology2017

Development and validation of a claims-based measure as an indicator for disease status in patients with multiple sclerosis treated with disease-modifying drugs.

Michael Munsell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.